Riskpilot← Back to searchSign inGet full accessHøreklinikken Glostrup ApS
APSActiveCVR 40607803Hovedvejen 118Medical specialists activities · NACE 8622Est. 2019— employees
Revenue 2025
DKK -87K
+1367% vs 2024
EBITDA margin
100.0%
-1367% vs 2024
Equity ratio
0.7%
Financial strength
Net profit 2025
DKK -87K
-1470% vs 2024
| Revenue | DKK -87K | +1367% |
| EBITDA | DKK -87K | -1367% |
| Net profit | DKK -87K | -1470% |
| Total assets | DKK 15K | -84% |
| Equity | DKK 100 | -100% |
| Employees | — | — |
Legal name
Høreklinikken Glostrup ApS
CVR number
40607803
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
21. juni 2019
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive virksomhed indenfor salg, service og industri og anden virksomhed beslægtet hermed.
Address
Hovedvejen 118
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 12 | 448 | 177 | 89 | 0 | -6 | -87 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 12 | 448 | 177 | 89 | 0 | -6 | -87 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 12 | 448 | 177 | 89 | 0 | -6 | -87 |
| Net financials | -0 | -4 | -8 | -3 | 0 | 0 | 0 |
| Profit before tax | 11 | 444 | 169 | 86 | 0 | -6 | -87 |
| Tax | 3 | 98 | 38 | 19 | 0 | -0 | -0 |
| Net profit | 9 | 346 | 131 | 67 | 0 | -6 | -87 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 268 | 631 | 286 | 210 | 101 | 96 | 15 |
| Equity | 49 | 395 | 226 | 193 | 93 | 87 | 0 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 219 | 237 | 61 | 17 | 8 | 9 | 15 |
| Total debt | 219 | 237 | 61 | 17 | 8 | 9 | 15 |
EBITDA margin
-8728600.0%
This company
15.8%
Market median
-55244404% vs market
20192025
Equity ratio
0.7%
This company
38.2%
Market median
-98% vs market
20192025
Return on equity
-87148.0%
This company
18.4%
Market median
-473730% vs market
20192025
Net profit margin
-8714800.0%
This company
8.1%
Market median
-107590223% vs market
20192025
Asset turnover
-5.68×
This company
1.12×
Market median
-607% vs market
20192025
Debt / equity
152.63×
This company
0.62×
Market median
-24518% vs market
20192025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-06-21 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MP Management | Management | 2019 | — | — |
MB Management | Management | 2019 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
AUDITIVA ApS | Company | 50.0% | 50.0% | 2019 |
MICH. BERG HOLDING ApS | Company | 50.0% | 50.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MICH. BERG HOLDING ApS
Høreklinikken Glostrup ApS Board members of Høreklinikken Glostrup ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Parsberg | Management | 0 companies |
| Michael Berg Jensen | Management | 0 companies |